Relugolix for treating hormone-sensitive prostate cancer

Final draft guidance

Final draft guidance (PDF 280 KB)

Equality impact assessment (downloadable version) (PDF 146 KB)

Register of interests (PDF 166 KB)

Final scope (PDF 184 KB)

Final stakeholder list (PDF 164 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 339 KB)

Equality impact assessment (Scoping) (PDF 125 KB)

Draft matrix post referral (PDF 167 KB)

Draft scope post referral (PDF 194 KB)